Supply Chain

Len Schleifer, CEO of Regeneron Pharmaceuticals, criticized Thousand Oaks, Calif.-based Amgen for putting its own financial success ahead of patients, reports Reuters.

The Oklahoma Health Care Authority and the Oklahoma Department of Mental Health have collaborated to provide the opioid overdose reversal drug naloxone to youths 19 years old and younger in areas of the state with high rates of opioid abuse,…

St. Jude Medical, which Abbott Laboratories acquired in 2016, is releasing new cybersecurity updates for its implanted heart devices. The move comes five months after a government launched an investigation into the devices over claims they were vulnerable to dangerous…

The Food and Drug Administration on Monday approved Egalet Corp.'s long-acting opioid painkiller Arymo ER, reports Reuters.

DaVita, a Denver-based independent medical group and kidney care services provider, entered into a six-year supply agreement with Thousand Oaks, Calif.-based Amgen.

U.S. District Judge Sue Robinson of Delaware on Jan. 5 granted Amgen's request for a permanent injunction to block Sanofi and Regeneron Pharmaceuticals from marketing its cholesterol drug Praluent, reports National Law Journal.

Transportation and warehousing companies added 14,700 jobs last month, according to the U.S. Department of Labor.

While black people have one of the highest rates of type 2 diabetes in the country, this population is largely underrepresented in drug trials exploring new treatments for the condition, according to a new study published in The Lancet.

Deerfield, Ill.-based Takeda Pharmaceuticals entered into a definitive agreement to acquire Cambridge, Mass.-based ARIAD Pharmaceuticals at $24 per share for a total of $5.2 billion.

U.S. Sen. Amy Klobuchar (D-Minn.) is urging Teleflex Medical to take immediate action in correcting an issue with its nasal applicators for the opioid overdose drug naloxone, reports the StarTribune.